MedTrace Logo

Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal

NCT00109551 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 58000

Last updated 2013-05-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether daily supplementation of young children in Nepal with either zinc, iron-folic acid, or both can reduce mortality and morbidity. Young children in Nepal have numerous nutritional deficiencies and high rates of morbidity and mortality. Zinc and/or iron supplementation may be a cost-effective method for reducing these risks.

Conditions

  • Nutrition

Interventions

DRUG

zinc sulphate dietary supplement

DRUG

iron sulphate-folic acid dietary supplement

Sponsors & Collaborators

  • United States Agency for International Development (USAID)

    collaborator FED

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    lead NIH

Principal Investigators

  • James M Tielsch, PhD · Johns Hopkins Bloomberg School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
1 Month
Max Age
36 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-10-31
Completion
2006-01-31

Countries

  • United States
  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00109551 on ClinicalTrials.gov